Search
for

    Sort by

    Research 91–120 of 1000+

    1. Medikamentöse Therapie der BPH Ist eine Kombinationstherapie mit 5α-Reduktasehemmern und α-Rezeptorenblockern sinnvoll? Der Urologe · 2002 · 4 citations
    2. Efficacy and safety of α-blockers plus 5α-reductase inhibitors for benign prostatic hyperplasia: a systematic review and meta-analysis European journal of medical research · 2026
    3. Dutasteride Drugs · 2008 · 45 citations
    4. The effects of lovastatin on conventional medical treatment of lower urinary tract symptoms with finasteride International Braz J Urol · 2008 · 24 citations
    5. Effect of metabolic syndrome on treatment outcome of lower urinary tract symptoms in males due to benign prostatic hyperplasia Panacea Journal of Medical Sciences · 2020 · 1 citations
    6. Efficacy, safety, and adverse effects of finasteride and dutasteride in treating benign prostatic hyperplasia: A retrospective cohort study Zanco Journal of Medical Sciences · 2024
    7. THE TREATMENT OF BPH WITH HYPERTENSION Journal of Beijing Normal University · 2008
    8. The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic Hyperplasia The New England Journal of Medicine · 1998 · 1054 citations
    9. Physiological and histological study of the effect of finasteride drug (Prostacare) on the fertility of albino male rats Research Journal of Pharmacy and Technology · 2018 · 5 citations
    10. Analyzing finasteride data Neurourology and Urodynamics · 1995 · 6 citations
    11. 5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia Actas urológicas españolas · 2018
    12. Finasteride en de preventie van prostaatcarcinoom Medisch-Farmaceutische Mededelingen · 2004
    13. 40gm 미만의 전립선비대증에서 α-차단제와 Finasteride 병합요법의 유용성 2003
    14. Editorial Comment Urology · 2013 · 3 citations
    15. Low-dose finasteride in benign prostatic hyperplasia: a comprehensive narrative review of efficacy, safety, and preventative potential Translational Andrology and Urology · 2026
    16. Pharmacological Role and Clinical Applications of 5α-Reductase Inhibitors-Review Article for Pharmacists and Healthcare Professionals 2025
    17. 5α‐Reductase Inhibitors 2014
    18. Influence of tamsulosin and finasteride on circadian rhythm and cardiac function in male elderly patients with chronic heart failure Shiyong laonian yixue · 2014
    19. Major role for 5-alpha reductase inhibitors in the aging male Canadian Urological Association Journal · 2012
    20. Evaluation of men on finasteride. PubMed · 1996 · 3 citations
    21. Successes and failures of evidence based urology 2005
    22. A concise review- Development of an analytical method and validation of dutasteride Current Trends in Pharmacy and Pharmaceutical Chemistry · 2025
    23. Current treatment of BPH Biomedicine & pharmacotherapy · 1995 · 11 citations
    24. Dutasteride: a review of current data on a novel dual inhibitor of 5alpha reductase. PubMed · 2005 · 38 citations
    25. Medikamentöse Therapie des benignen Prostatasyndroms Der Urologe · 2015 · 20 citations
    26. The Benefits of Dual Inhibition of 5α Reductase European Urology Supplements · 2006 · 4 citations
    27. Pharmacological Role and Clinical Applications of 5α-Reductase Inhibitors-Review Article for Pharmacists and Healthcare Professionals 2025
    28. Les Visiteurs des malades Nature Clinical Practice Urology · 2011
    29. Acute prostatitis in german shepherds -a report of two cases INTAS POLIVET · 2010 · 1 citations
    30. Endocrine control of benign prostatic hyperplasia Andrology · 2016 · 97 citations